UnitedHealth Group (UNH) Stock Forecast & Price Target

UnitedHealth Group is projected to experience significant earnings growth, with overall earnings expected to increase by 13% in 2026, largely attributed to margin enhancements in both the Medicare and commercial segments. The Optum franchises, which encompass pharmaceutical benefits and outpatient care, are anticipated to grow earnings across multiple segments—Optum Health by approximately 9%, Optum Rx by around 2%, and Optum Insight by up to 4%, all while improving margins. Additionally, the vertical integration strategy further bolsters the company's competitive edge within the healthcare industry, facilitating an expected increase in Medicare operating margins from 2.3% in 2025 to 3.0% in 2026, which supports a positive long-term outlook for UnitedHealth Group's stock.

UnitedHealth Group is facing significant membership declines projected at 1.3-1.4 million across its Medicare Advantage (MA) segment and a substantial drop of 300,000 lives in its Medicaid business due to work requirement changes, indicating potential erosion in its customer base. Furthermore, anticipated margins for its commercial risk business are expected to fall, compounded by sluggish growth in Medicare Advantage rates projected at only 0.09%, which is well below industry expectations and inflationary pressures. Overall, these factors contribute to a negative outlook, suggesting challenges in sustaining profitability as membership dwindles and operational margins shrink.